Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticlePROCEEDINGS OF THE 19TH ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES, 5 December 2015 (Tokyo, Japan)

Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4

RYOHEI KOIDE, KASEM KULKEAW, YUKA TANAKA, ANTHONY SWAIN, YOICHI NAKANISHI and DAISUKE SUGIYAMA
Anticancer Research July 2016, 36 (7) 3635-3643;
RYOHEI KOIDE
1Department of Research and Development of Next Generation Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KASEM KULKEAW
1Department of Research and Development of Next Generation Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKA TANAKA
2Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
3Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTHONY SWAIN
1Department of Research and Development of Next Generation Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
2Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
4Center for Clinical and Translational Research, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOICHI NAKANISHI
4Center for Clinical and Translational Research, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAISUKE SUGIYAMA
1Department of Research and Development of Next Generation Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
4Center for Clinical and Translational Research, Kyushu University, Fukuoka, Japan
5Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ds-mons{at}yb3.so-net.ne.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Gene and protein expression of aryl hydrocarbon receptor (AHR) in leukemia cell lines. A: Relative expression of AHR mRNA in the four leukemia cell lines Jurkat, Kasumi-1, NB4, and K562 as measured by real-time polymerase chain reaction. N.D.: Not detected, **p<0.01. B: Immunocytochemical images of AHR protein (green) in NB4 cells. Nucleic acid is stained with TOTO-3 iodide (blue). Scale bar=20 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Effect of StemRegenin 1 (SR1) on cell proliferation and death of NB4 cells. NB4 cells were cultured in the presence of three different concentrations of SR1 [0.375 μM, 0.75 μM and 1.5 μM containing 0.1% dimethyl sulfoxide (DMSO)] or 0.1% DMSO only (control) for up to 4 days. A: The number of viable cells was determined at days 0, 2 and 4. **p<0.01. B: The percentage of dead cells at day 2 and 4 of culture was determined. n.s.: Not significant, *p<0.05, **p<0.01. C: Images of the cells under the microscope at day 2 and 4 of culture. D: Images of May-Grünwald Giemsa staining at day 4 of culture. Scale bar=20 μm.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    StemRegenin 1 (SR1) up-regulated cell proliferation- and apoptosis-related genes in the NB4 cell line. Relative expression of B-cell CLL/lymphoma 2 (BCL2), BCL2 associated X protein (BAX), myeloid cell leukemia 1 (MCL1), cyclin D1 (CCND1), CCND2 and v-myc avian myelocytomatosis viral oncogene homolog (MYC) mRNAs of NB4 cells cultured with 1.5 μM SR1 containing 0.1% DMSO, or 0.1% DMSO only (control) were measured by real-time polymerase chain reaction. A: Expression of BCL2, BAX, MCL1, CCND1, CCND2 and MYC at day 2. B: Expression of CCND1, CCND2 and MYC at day 4. n.s.: Not significant, *p<0.05, **p<0.01.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Effect of StemRegenin 1 (SR1) on gene-expression profiles of the NB4 cell line. A: Scatter plot of DNA microarray comparing the signals in control with those in NB4 cells treated with SR1 for 4 days. Significantly up- (red) and down- (blue) regulated genes are indicated. B: Gene functional annotation using the DAVID software. The up- (left) and down- (right) regulated genes functional annotations with the top 10 are shown in order of significant difference from those of the control.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 36, Issue 7
July 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4
RYOHEI KOIDE, KASEM KULKEAW, YUKA TANAKA, ANTHONY SWAIN, YOICHI NAKANISHI, DAISUKE SUGIYAMA
Anticancer Research Jul 2016, 36 (7) 3635-3643;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4
RYOHEI KOIDE, KASEM KULKEAW, YUKA TANAKA, ANTHONY SWAIN, YOICHI NAKANISHI, DAISUKE SUGIYAMA
Anticancer Research Jul 2016, 36 (7) 3635-3643;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Pdx1 expression in hematopoietic cells activates Kras-mutation to drive leukemia in KC (Pdx1-Cre ; LSL-KrasG12D/+) mice
  • Google Scholar

More in this TOC Section

  • Biomimetic Peptides for the Treatment of Cancer
  • Development of an Evaluation Device for Phagocytic Activity of New Phagocytes Using Simple and pH-sensitive Particles that Do Not Require Pre-treatment
  • Clinical Effects of Orally Administered Lipopolysaccharide Derived from Pantoea agglomerans on Malignant Tumors
Show more PROCEEDINGS OF THE 19TH ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES, 5 December 2015 (Tokyo, Japan)

Keywords

  • aryl hydrocarbon receptor
  • StemRegenin 1
  • NB4 cells
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire